Skip to main content


April 07, 2021
Jessica Whelan, DNP, APRN, FPMHNP-BC reviews the many factors that come in to play when she is developing a treatment plan for her patients with bipolar disorder.
April 07, 2021
In this video, Randall Espinoza, MD, MPH, from the Geffen School of Medicine at UCLA, discusses the epidemiology, impact, and management of treatment-resistant depression in older adults.
April 06, 2021
Jonathan E. Alpert, MD, PhD, discusses which medical conditions are associated with high rates of depression and evidence gaps in the research on people with depression and medical comorbidities.
April 05, 2021
Psychedelic Medicine Association president Lynn Marie Morski, MD, Esq., a Sana Symposium steering committee member, discusses the mission of the Psychedelic Medicine Association, bringing…
March 30, 2021
Jessica Whelan, DNP, APRN, FPMHNP-BC discusses the value of understanding the neurobiology behind bipolar disorder and how she explains it to her patients.
March 29, 2021
In recognition of World Bipolar Day, held annually on March 30, Bipolar Disorders Section Editor Joseph F. Goldberg, MD, shares advice for mental health clinicians on steps to take before diagnosing…
March 26, 2021
ADHD Section Editor and Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses recent research developments regarding late-onset ADHD and questions that remain…
March 22, 2021
Sana Symposium steering committee member Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at the Texas Tech University Health Sciences Center School of Medicine and co-…
March 11, 2021
Joseph F. Goldberg, MD, explains why is it important for clinicians treating bipolar disorder to consider both moderators and mediators of treatment outcomes.
March 11, 2021
Psych Congress co-chair and researcher Charles Raison, MD, recently spoke with David Van Nuys, PhD, on the Shrink Rap Radio podcast about depression, traditional antidepressants, and psychedelic-…
Back to Top